Drug intelligence / Profile preview

niacinamide butyrate

Development stage
Preclinical
Lead developer
Xuzhou Medical University
Modality
Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Niacinamide butyrate is a butyrate-based ionic liquid (IL) composed of a niacinamide (nicotinamide) cation and a butyrate anion. It is primarily investigated as a functional pharmaceutical ingredient or solvent to enhance the oral bioavailability and therapeutic efficacy of poorly soluble drugs, such as glycyrol. Beyond its role as a delivery vehicle, it exhibits intrinsic biological activity; butyrate acts as a histone deacetylase (HDAC) inhibitor and a source of energy for colonocytes, while niacinamide is a precursor to nicotinamide adenine dinucleotide (NAD+). In preclinical models of colorectal cancer, niacinamide butyrate has demonstrated synergistic anti-tumor effects when combined with other phytochemicals by modulating apoptotic pathways and improving drug solubility.

Other names
nicotinamide butyratenicotinamidium butyrate
02

Targets

SIRT (Sirtuin family)HCAR2 (Hydroxycarboxylic acid receptor 2)HDAC (HDAC family)

Beyond the preview

Go deeper on niacinamide butyrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on niacinamide butyrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call